Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
50
OSCR Quote, Financials, Valuation and Earnings
Last price:
$14.95
Seasonality move
:
31.49%
Day range:
$14.62 - $14.99
52-week range:
$11.20 - $23.80
Dividend yield:
0%
P/E ratio:
51.21x
P/S ratio:
0.35x
P/B ratio:
4.17x
Volume:
7.6M
Avg. volume:
11.9M
1-year change:
9.12%
Market cap:
$4.3B
Revenue:
$9.2B
EPS (TTM):
-$1.12
Analysts' Opinion
-
Consensus RatingOscar Health, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 3 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $14.67, Oscar Health, Inc. has an estimated downside of -1.17% from its current price of $14.84.
-
Price Target UpsideAccording to analysts, the highest upside price target is $25.00 representing -100% upside increase from its current price of $14.84.
Fair Value
-
According to the consensus of 7 analysts, Oscar Health, Inc. has -1.17% downside to fair value with a price target of $14.67 per share.
OSCR vs. S&P 500
-
Over the past 5 trading days, Oscar Health, Inc. has underperformed the S&P 500 by -7.38% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Oscar Health, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Oscar Health, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Oscar Health, Inc. reported revenues of $3B.
Earnings Growth
-
Oscar Health, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Oscar Health, Inc. reported earnings per share of -$0.53.
Enterprise value:
5B
EV / Invested capital:
2.90x
Price / LTM sales:
0.35x
EV / EBIT:
5.79x
EV / Revenue:
0.44x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
6.75x
Price / Operating cash flow:
5.39x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-4.65%
Net Income Margin (TTM):
-2.16%
Return On Equity:
-21.36%
Return On Invested Capital:
-16.06%
Operating Margin:
-4.33%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $5.4B | $8.2B | $11.3B | $2.4B | $3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -$312.6M | $59.5M | -$210.3M | -$48.4M | -$129.3M | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -$1.60 | -$0.06 | -$1.12 | -$0.22 | -$0.53 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $3.1B | $2.7B | $2.1B | $3.6B | |
| Total Assets | $2.8B | $3.5B | $3.1B | $4.2B | $5.6B | |
| Current Liabilities | $1.2B | $2B | $1.8B | $2.7B | $3.8B | |
| Total Liabilities | $1.2B | $2.4B | $2.2B | $3B | $4.6B | |
| Total Equity | $1.6B | $1.1B | $921.4M | $1.2B | $1B | |
| Total Debt | -- | $297.8M | $298.6M | $299.4M | $686.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$417.6M | $928.2M | $769.8M | -$500.1M | -$964.7M | |
| Cash From Investing | -$302M | -$1.2B | -$223.8M | -$577.8M | $150.1M | |
| Cash From Financing | $5.9M | $65.6M | $394.9M | $18.6M | $364M | |
| Free Cash Flow | -$444.2M | $901.1M | $735.6M | -$507.7M | -$973.7M | |
OSCR
Sector
Market Cap
$4.3B
$570M
Price % of 52-Week High
62.35%
92.18%
Dividend Yield
0%
1.57%
Shareholder Yield
-2.49%
3.12%
1-Year Price Total Return
9.12%
7.87%
Beta (5-Year)
--
0.478
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$15.43
200-day SMA
Sell
Level
$16.06
Bollinger Bands (100)
Sell
Level
15.18 - 19.62
Chaikin Money Flow
Sell
Level
-271.3M
20-day SMA
Sell
Level
$16.30
Relative Strength Index (RSI14)
Sell
Level
41.00
ADX Line
Sell
Level
13
Williams %R
Buy
Level
-92.635
50-day SMA
Sell
Level
$16.96
MACD (12, 26)
Sell
Level
-0.46
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Sell
Level
-91.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.573)
Sell
CA Score
(Annual)
Level (-0.755)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-3.9658)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
Stock Forecast FAQ
In the current month, OSCR has received 0 Buy ratings 4 Hold ratings, and 3 Sell ratings. The OSCR average analyst price target in the past 3 months is $14.67.
-
Where Will Oscar Health, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Oscar Health, Inc. share price will drop to $14.67 per share over the next 12 months.
-
What Do Analysts Say About Oscar Health, Inc.?
Analysts are divided on their view about Oscar Health, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that Oscar Health, Inc. is a Buy and believe this share price will rise from its current level to $25.00.
-
What Is Oscar Health, Inc.'s Price Target?
The price target for Oscar Health, Inc. over the next 1-year time period is forecast to be $14.67 according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 3 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is OSCR A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Oscar Health, Inc. is a Hold. 4 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of OSCR?
You can purchase shares of Oscar Health, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Oscar Health, Inc. shares.
-
What Is The Oscar Health, Inc. Share Price Today?
Oscar Health, Inc. was last trading at $14.95 per share. This represents the most recent stock quote for Oscar Health, Inc.. Yesterday, Oscar Health, Inc. closed at $14.84 per share.
-
How To Buy Oscar Health, Inc. Stock Online?
In order to purchase Oscar Health, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OSCR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OSCR
Sector
P/E ratio
51.21x
12.24x
PEG ratio
-0.01x
0.31x
P/B ratio
4.17x
1.11x
Price / LTM sales
0.35x
1.84x
Growth Metrics
OSCR
Sector
Revenue growth
23.21%
5.54%
Earnings growth
-136.02%
14.85%
Revenue (5-year growth)
79.82%
8.84%
Earnings forecast
-$0.58
$0.62
Profitability
OSCR
Sector
Profitability FY 2024
--
--
Return on invested capital
-16.06%
5.01%
Return on assets
-4.65%
1.01%
Return on equity
-21.36%
9.68%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
3
Estimated Next Earnings Date
Feb
5
Balance Sheet
OSCR
Sector
Total cash
$3.5B
$431.4M
Short term investments
$624.5M
$211.3M
Total assets
$4.5B
$3.1B
Long term debt
$686.3M
$79M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
